These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 7510058)

  • 1. Inhibitory effect of nitric oxide (NO) synthase inhibitors on naloxone-precipitated withdrawal syndrome in morphine-dependent mice.
    Cappendijk SL; de Vries R; Dzoljic MR
    Neurosci Lett; 1993 Nov; 162(1-2):97-100. PubMed ID: 7510058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase.
    Kimes AS; Vaupel DB; London ED
    Psychopharmacology (Berl); 1993; 112(4):521-4. PubMed ID: 7532866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of nitric oxide synthase and the opioid withdrawal syndrome.
    London ED; Kimes AS; Vaupel DB
    NIDA Res Monogr; 1995; 147():170-81. PubMed ID: 8742786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the morphine withdrawal syndrome by a nitric oxide synthase inhibitor, NG-nitro-L-arginine methyl ester.
    Adams ML; Kalicki JM; Meyer ER; Cicero TJ
    Life Sci; 1993; 52(22):PL245-9. PubMed ID: 7684108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice.
    Majeed NH; Przewłocka B; Machelska H; Przewłocki R
    Neuropharmacology; 1994 Feb; 33(2):189-92. PubMed ID: 7518573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of simultaneous administration of alpha(2) -adrenergic agents with L-NAME or L-arginine on the development and expression of morphine dependence in mice.
    Zarrindast MR; Homayoun H; Khavandgar S; Fayaz-Dastgerdi M; Fayaz-Dastgerdi M
    Behav Pharmacol; 2002 Mar; 13(2):117-25. PubMed ID: 11981224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a role of nitric oxide of the central nervous system in morphine abstinence syndrome.
    Bhargava HN; Thorat SN
    Pharmacology; 1996 Feb; 52(2):86-91. PubMed ID: 8851629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of nitric oxide in the induction and expression of morphine tolerance and dependence in mice.
    Dambisya YM; Lee TL
    Br J Pharmacol; 1996 Mar; 117(5):914-8. PubMed ID: 8851510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinal NMDA receptor--nitric oxide mediation of the expression of morphine withdrawal symptoms in the rat.
    Buccafusco JJ; Terry AV; Shuster L
    Brain Res; 1995 May; 679(2):189-99. PubMed ID: 7633880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of normotensive and hypertensive nitric oxide synthase inhibitors on morphine withdrawal syndrome in rats.
    Cappendijk SL; Duval SY; de Vries R; Dzoljic MR
    Neurosci Lett; 1995 Jan; 183(1-2):67-70. PubMed ID: 7538210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide synthase inhibitors attenuate acute and chronic morphine withdrawal response in the rat locus coeruleus: an in vivo voltammetric study.
    Hall S; Milne B; Jhamandas K
    Brain Res; 1996 Nov; 739(1-2):182-91. PubMed ID: 8955938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylmethanesulfonyl fluoride, a serine protease inhibitor, suppresses naloxone-precipitated withdrawal jumping in morphine-dependent mice.
    Nemoto W; Sato T; Nakagawasai O; Yaoita F; Silberring J; Tadano T; Tan-No K
    Neuropeptides; 2013 Jun; 47(3):187-91. PubMed ID: 23290539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of NG-monomethyl-L-arginine and MK-801 on the abstinence syndrome in morphine-dependent mice.
    Thorat SN; Barjavel MJ; Matwyshyn GA; Bhargava HN
    Brain Res; 1994 Apr; 642(1-2):153-9. PubMed ID: 7518322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of morphine tolerance and dependence by aminoguanidine in mice.
    Abdel-Zaher AO; Hamdy MM; Aly SA; Abdel-Hady RH; Abdel-Rahman S
    Eur J Pharmacol; 2006 Jul; 540(1-3):60-6. PubMed ID: 16730698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine suppresses morphine tolerance and dependence: modulation of NO-cGMP/DA/serotoninergic pathways.
    Singh VP; Jain NK; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 2003 May; 25(4):273-80. PubMed ID: 12808472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of specific and nonspecific inhibition of nitric oxide synthase on morphine analgesia, tolerance and dependence in mice.
    Ozek M; Uresin Y; Güngör M
    Life Sci; 2003 Mar; 72(17):1943-51. PubMed ID: 12597993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-nociceptive activity of nitric oxide synthase inhibitors in the mouse: dissociation between the effect of L-NAME and L-NMMA.
    Babbedge RC; Hart SL; Moore PK
    J Pharm Pharmacol; 1993 Jan; 45(1):77-9. PubMed ID: 7679442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between brain nitric oxide synthase activity and opiate withdrawal.
    Leza JC; Lizasoain I; Cuéllar B; Moro MA; Lorenzo P
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):349-54. PubMed ID: 8692292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible mechanisms of action in melatonin reversal of morphine tolerance and dependence in mice.
    Raghavendra V; Kulkarni SK
    Eur J Pharmacol; 2000 Dec; 409(3):279-89. PubMed ID: 11108822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide synthase inhibitors. Preclinical studies of potential use for treatment of opioid withdrawal.
    Vaupel DB; Kimes AS; London ED
    Neuropsychopharmacology; 1995 Dec; 13(4):315-22. PubMed ID: 8747756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.